RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer

by Moreno-Aspitia, Alvaro, Dueck, Amylou C., Ghanem-Cañete, Ismael, Patel, Tejal, Dakhil, Shaker, Johnson, David, Franco, Sandra, Kahanic, Stephen, Colon-Otero, Gerardo, Tenner, Kathleen S., Rodeheffer, Richard, McCullough, Ann E., Jenkins, Robert B., Palmieri, Frances M., Northfelt, Donald, Perez, Edith A.
Published 2013